secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-02-13T23:59:59+00:00
Accession:  0000950170-23-002646
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs gets Nasdaq extension until June 19, 2023 to regain equity compliance
--------------------------------------------------------------------------------

- Stockholders' equity was $1,082,676 as of Oct 31, 2022, below Nasdaq's $2.5M minimum for continued listing.
- Nasdaq granted extension to June 19, 2023 after company submitted a compliance plan.
- Company must file a public report describing the transaction/event that restores compliance.
- If not compliant by April 30, 2023 filing, Nasdaq may delist; company can appeal to a Hearings Panel.
- Warrants (HSCSW) also listed on Nasdaq and subject to same continued listing requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023002646/0000950170-23-002646-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023002646/hscs-20230208.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-002646

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer